EUCTR2011-004610-42-GB进行中（未招募）不适用
Evaluation of topical ibuprofen and steroid in the reduction of local reactions and symptoms from an Aedes aegypti mosquito bite - Evaluation of anti-inflamatories for the reduction of Mosquito bites
ondon School of Hygiene and Tropical Medicine0 个研究点开始时间: 2011年11月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •18 to 65 years of age (inclusive). Caucasian (white or pale skin) Good health as determined by medical history and physical examination Females of child bearing potential ?must have a negative pregnancy test / must confirm they are not pregnant at the study start and agree not to become pregnant throughout the duration of the study. . History of the following triad of symptoms following a previous mosquito bite: weal, flare, and pruritus as immediate reaction to mosquito bites at least once in the past (= mosquito bite sensitive stages III or IV). Willingness to attend for all study procedures at designated intervals. Willingness to provide full consent to the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
- •18 to 65 years of age (inclusive). Caucasian (white or pale skin) Good health as determined by medical history and physical examination Females of child bearing potential ?must have a negative pregnancy test / must confirm they are not pregnant at the study start and agree not to become pregnant throughout the duration of the study. . History of the following triad of symptoms following a previous mosquito bite: weal, flare, and pruritus as immediate reaction to mosquito bites at least once in the past (= mosquito bite sensitive stages III or IV). Willingness to attend for all study procedures at designated intervals. Willingness to provide full consent to the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Abnormalities of the skin on the forearms (including sunburn) that might interfere with the study results, as determined by the investigator/clinician during physical inspection. History of clinically significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, haematological, endocrine, metabolic, or other disease deemed clinically significant by investigator / clinician Use of prohibited therapies (including cosmetics on either forearm) as specified in Section 6.3.3 of the Clinical Trial Protocol (use of systemic or local antihistamines, steroids, or NSAIDs during or within 2 weeks prior to planned date of first study procedure); use of any medication considered to have an influence on the outcome of the study. Any acute illness within the 7 days prior to planned date of first study procedure which might interfere with the study results (as determined by the investigator/clinician from medical history). History of malignancy within 5 years of the planned date of the first study procedure Neurological or psychiatric disease, or drug or alcohol abuse which would interfere with the subject's completion of the protocol assignments. Participated in research involving an investigational drug within 3 months of the planned date of first study procedure. History of known anaphylactic hypersensitivity to mosquitoes bites, bee or wasp stings. History of allergic reaction to any of the topical agents used in the study or any of their components. History of allergy to latex or other rubber material Women who are pregnant or breastfeeding history of recent travel to a region where mosquito borne disease are present. 13) Safety concerns: 14) History of hypersensitivity to stings of mosquitoes, bees, or wasps. 15) History of allergic reaction to the trial medication or its ingredients. 16) History of allergy to Latex or other rubber materials. 17) Lactating female or female of child-bearing potential not using adequate contraception.
- •Abnormalities of the skin on the forearms (including sunburn) that might interfere with the study results, as determined by the investigator/clinician during physical inspection. History of clinically significant cardiovascular, pulmonary, hepatic, renal, gastrointestinal, haematological, endocrine, metabolic, or other disease deemed clinically significant by investigator / clinician Use of prohibited therapies (including cosmetics on either forearm) as specified in Section 6.3.3 of the Clinical Trial Protocol (use of systemic or local antihistamines, steroids, or NSAIDs during or within 2 weeks prior to planned date of first study procedure); use of any medication considered to have an influence on the outcome of the study. Any acute illness within the 7 days prior to planned date of first study procedure which might interfere with the study results (as determined by the investigator/clinician from medical history). History of malignancy within 5 years of the planned date of the first study procedure Neurological or psychiatric disease, or drug or alcohol abuse which would interfere with the subject's completion of the protocol assignments. Participated in research involving an investigational drug within 3 months of the planned date of first study procedure. History of known anaphylactic hypersensitivity to mosquitoes bites, bee or wasp stings. History of allergic reaction to any of the topical agents used in the study or any of their components. History of allergy to latex or other rubber material Women who are pregnant or breastfeeding history of recent travel to a region where mosquito borne disease are present. 13) Safety concerns: 14) History of hypersensitivity to stings of mosquitoes, bees, or wasps. 15) History of allergic reaction to the trial medication or its ingredients. 16) History of allergy to Latex or other rubber materials. 17) Lactating female or female of child-bearing potential not using adequate contraception.
研究者
相似试验
已完成
4 期
Evaluation of Anti-inflammatories in the Reduction of Bite ReactionsMosquito BiteNCT01452997London School of Hygiene and Tropical Medicine40
尚未招募
不适用
A clinical trial to study the effect of combined topical steroid therapy and psychotherapeutic interventions on the clinical resolution of Oral Lichen Planus.CTRI/2021/10/037583Rajiv Gandhi University Of Health Science
招募中
2 期
Safety and efficacy of topical steroid administration in patients undergoing mandibular horizontal impacted wisdom tooth extractioJPRN-jRCTs071210140aruse Tomofumi246
招募中
2 期
The effect of topical and oral ibuprofen on pain reliefImpacted tooth.IRCT20210501051150N1Islamic Azad University20
已完成
4 期
Effects of post-operative topical steroid versus intraoperative subconjunctival steroid injection and postoperative miotic on intraocular inflammation following cataract extraction.inflammation of the eye after cataract surgery10021877NL-OMON34332Oogziekenhuis Rotterdam400